Reviva Pharmaceuticals I... (RVPH)
NASDAQ: RVPH
· Real-Time Price · USD
0.35
-0.41 (-54.17%)
At close: Jun 26, 2025, 3:59 PM
Reviva Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -6.26M | -8.37M | -7.86M | -7.43M | -9.72M | -11.35M | -12.44M | -6.6M | -8.12M | -3.52M | -5.34M | -7.37M | -3.68M | -2.28M | -1.61M | -949.3K |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 554.22K | 348.06K | 358.99K | 369.07K | 390.6K | 350.41K | 2.62M | 51.53K | 56.59K | 40.59K | 39.88K | 39.69K | 62.03K | 27.59K | n/a | n/a |
Other Working Capital | -769.08K | -235.58K | 252.11K | -6.08M | 1.95M | 2.33M | 4.26M | 659.69K | 1.53M | -283.61K | 278.28K | 472.63K | -129.81K | 80.05K | 552.77K | -706.72K |
Other Non-Cash Items | 11.13K | -72.32K | -200.27K | -456.18K | -66.76K | -139.08K | 456.18K | -11.13K | 461.74K | n/a | -178.02K | -89.01K | -238.23K | -200.27K | -172.06K | -923.48K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -3.41M | 3.85M | -774.99K | -4.21M | 524.12K | 4.96M | 4.05M | -1.39M | 2.91M | -527.27K | 1.48M | 1.15M | -41.01K | 142.57K | 439.72K | -1.24M |
Operating Cash Flow | -9.1M | -4.24M | -8.48M | -11.73M | -8.88M | -6.18M | -5.32M | -7.95M | -4.69M | -4M | -4M | -6.27M | -3.9M | -2.31M | -1.34M | -3.12M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | 375.15K | n/a | -124.5K | 332K | -222.5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -124.47K | 2.81M | n/a | n/a | n/a | n/a | 687.09K | -7.77B | 333.00 | n/a | 70.00 | 60.95K | -607.6K | 31.5M | n/a |
Financial Cash Flow | 17.02M | 3.62M | 2.68M | 332K | 27.27M | n/a | 5.21M | 687.09K | 18.56K | 7.77M | n/a | 70.00 | 98.48K | -610K | 31.5M | n/a |
Net Cash Flow | 7.92M | -619.36K | -5.8M | -11.39M | 18.4M | -6.18M | -103.97K | -7.26M | -4.67M | 3.77M | -4M | -6.27M | -3.8M | -2.31M | 30.16M | -3.12M |
Free Cash Flow | -9.1M | -4.24M | -8.48M | -11.73M | -8.88M | -6.18M | -5.32M | -7.95M | -4.69M | -4M | -4M | -6.27M | -3.9M | -2.31M | -1.34M | -3.12M |